Articles on pre-exposure prophylaxis

Displaying all articles

Pre-exposure prophylaxis is providing an exciting new innovation to tackle HIV prevention. shutterstock

Rings and things … other ways to prevent HIV are on the cards

Trials have shown that rates of HIV infection are reduced if people not infected with HIV take anti-retrovirals - known as pre-exposure prophylaxis (PrEP). But adherence to a daily dose is a problem.
Young women who attended the International AIDS Conference in Durban, South Africa. International AIDS Society/Rogan Ward

AIDS conference 2016: the gains, the gaps, the next global steps

The focus of the 2016 International AIDS Conference has on access to necessary antiretrovirals, equity and making sure no-one is left behind. But there is a funding gap that needs to be addressed.
Treatment has transformed the outlook for people living with HIV from almost certain death to a manageable chronic condition. Athit Perawongmetha/Reuters

The scientific journey of AIDS from despair to cautious hope

Despite the breakthroughs in HIV and AIDS research, without an effective vaccine, the world will not get to zero new infections and deaths.
The WHO has recommended pre-exposure prophylaxis, or PrEP, as an additional HIV prevention choice for people with a high risk of being infected. Truvada has been licensed in South Africa. Epa/Maurizio Gambarini

How a drug can help prevent 5000 girls being infected with HIV every week

Young women in southern Africa are most at risk of becoming infected with HIV. If they take a pre-exposure prophylaxis like Truvada it could change their lives.

Top contributors

More